UK markets closed

IDEXX Laboratories, Inc. (IX1.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
445.30-25.90 (-5.50%)
At close: 05:35PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,724,853
3,660,953
3,367,324
3,215,360
2,706,655
Cost of revenue
1,484,784
1,470,983
1,362,986
1,325,928
1,135,615
Gross profit
2,240,069
2,189,970
2,004,338
1,889,432
1,571,040
Operating expenses
Research development
198,919
190,951
254,820
161,009
141,249
Selling general and administrative
925,463
901,891
850,753
796,395
735,267
Total operating expenses
1,124,382
1,092,842
1,105,573
957,404
876,516
Operating income or loss
1,115,687
1,097,128
898,765
932,028
694,524
Interest expense
36,365
41,581
39,858
29,808
33,125
Income before tax
1,088,967
1,061,176
859,972
902,654
661,985
Income tax expense
222,400
216,134
180,883
157,810
79,854
Income from continuing operations
866,567
845,042
679,089
744,844
582,131
Net income
866,567
845,042
679,089
744,845
581,776
Net income available to common shareholders
866,567
845,042
679,089
744,845
581,776
Basic EPS
9.91
-
8.12
8.74
6.82
Diluted EPS
9.81
-
8.03
8.60
6.71
Basic average shares
83,025
-
83,623
85,200
85,342
Diluted average shares
83,949
-
84,600
86,572
86,722